comparemela.com

Latest Breaking News On - Mind medicine mindmed inc - Page 8 : comparemela.com

MindMed to Participate at the LifeSci Partners 11th Annual Corporate Access Event

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

Robert barrowPrnewswire mind medicine mindmed incMedicine mindmed incChief executive officerLifesci partnersAnnual corporate access eventMore than justMind medicine mindmed incHealth care amp hospitalsMental healthMedical pharmaceuticals

MindMed Announces Transitions to Management Team

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

Robert barrowDaniel karlinDon gehlertBradford crossMedicine mindmed incChief technology officerChief scientific officerSenior scientific advisorMind medicineChief executive officerMindmed chief medical officerSenior scientificSecurities litigation reform actMind medicine mindmed inc

MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

Robert barrowExchange commissionNational institute of mental healthDrug administrationPrnewswire mind medicine mindmed incMedicine mindmed incChief executive officerNational instituteMental healthMajor depressive disorderMind medicine mindmed inc

MindMed Provides Status Update on IND for Phase 2b Trial of LSD for the Treatment of Generalized Anxiety Disorder

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

Robert barrowExchange commissionNational institute of mental healthDrug administrationPrnewswire mind medicine mindmed incMedicine mindmed incChief executive officerNational instituteMental healthMajor depressive disorderMind medicine mindmed inc

MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD

/PRNewswire/ Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired.

United statesRobert barrowMatthias liechtiKim kuypersMiri halperin wernliMaastricht universityKim kuypers at maastricht universityPrnewswire mind medicine mindmed incUniversity hospital baselExchange commissionSphere healthMedicine mindmed incChief executive officerExecutive presidentHyperactivity disorderMind medicine mindmed inc

vimarsana © 2020. All Rights Reserved.